are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic disease. "A lot of patients respond ...

"Traditionally when a cancer has spread to other organs other than the original site of the disease patients were considered incurable. "However, there is a theory called the oligometastatic ...